Research

Aylesworth Scholar Highlight: Owen Silvera’s Insights on Sediment and Dangerous Algal Bloom Analysis in Lake Okeechobee Defend Cyber

by

Owen Silvera (pictured bottom-center) together with his analysis group at Lake Okeechobee. Picture by Owen Silvera. Within the early mornings and late nights, from dawn to sunset, graduate scholar Owen Silvera and his colleagues launched into numerous expeditions in Lake Okeechobee. “I recall spending complete days there, targeted on amassing sediment in hopes to disclose … Read more

Zacks Small Cap Analysis – ELTK: Eltek Studies 1st Quarter 2024 Monetary Outcomes Defend Cyber

by

By Thomas Kerr, CFA NASDAQ:ELTK READ THE FULL ELTK RESEARCH REPORT On Might 15, 2024, Eltek (NASDAQ:ELTK) introduced monetary outcomes for the first quarter of 2024 which have been largely in step with expectations. Revenues for the first quarter have been $11.8 million in comparison with $11.5 million within the 1st quarter of 2023. Gross … Read more

The clear decline of money and playing cards and rise of wallets [stats and research] Malik Atif

by

For over twenty years, I’ve predicted the tip of the ATM, money and playing cards. Lastly, lots of these predictions seem like coming true. It’s actually true of money versus card … … and now it’s turning out to be true for card versus pockets … Admittedly, the second image is from a cell funds … Read more

Zacks Small Cap Analysis – XFOR: XOLREMDI Permitted by FDA…

by

By David Bautz, PhD NASDAQ:XFOR READ THE FULL XFOR RESEARCH REPORT Enterprise Replace XOLREMDI Permitted by the FDA On April 29, 2024, X4 Prescription drugs, Inc. (NASDAQ:XFOR) introduced that the U.S. Meals and Drug Administration (FDA) has authorised XOLREMDI (mavorixafor) to be used in sufferers 12 years of age and older with WHIM syndrome (warts, … Read more